The overexpression of CRIP1 has been observed in several human malignant tumors, including cervical cancer, breast cancer, prostate cancer, colorectal cancer, pancreatic cancer, gastric cancer and osteosarcoma [7-11,13-15]. Here, CRIP1 is linked to osteosarcoma.